A Study of MK-1167 in Healthy Elderly Participants (MK-1167-004)

A Randomized, Double-Blind Clinical Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MK-1167 in Healthy Elderly Participants

The goal of this study is to learn how safe MK-1167 is in healthy elderly adults and how well people tolerate it.

The main inclusion criteria include but are not limited to the following:

• Be in good health

The main exclusion criteria include but are not limited to the following:

• History of clinically significant endocrine, GI, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases.
• History of cancer (malignancy).